文献速递神经介入DSA

脑膜中动脉动脉瘤与假性动脉瘤栓塞的安全性与疗效系统综述

Safety and Efficacy of Middle Meningeal Artery Aneurysm and Pseudoaneurysm Embolization: A Systematic Review.
PubMed 文献 · AJNR Am J Neuroradiol · 2026-02-03

本系统综述纳入28项研究/病例报告共31例接受脑膜中动脉栓塞治疗的脑膜中动脉动脉瘤或假性动脉瘤成人患者。结果显示全部病例均实现完全闭塞,90.32%患者症状改善,仅1例出现非目标栓塞并发症且无永久性缺损。栓塞材料以弹簧圈和n-BCA最为常用。

要点

  • 脑膜中动脉动脉瘤及假性动脉瘤栓塞后完全闭塞率高,症状改善率90.32%。
  • 栓塞前需警惕脑膜中动脉与大脑中动脉之间的隐匿吻合,避免非目标栓塞。
  • 创伤性病因占54.84%,是最主要的致病原因。

核心结论

  • 脑膜中动脉栓塞治疗动脉瘤和假性动脉瘤安全性及有效性良好,血管造影成功率较高,并发症轻微。

研究设计与样本

  • 本研究为系统综述,纳入针对18岁及以上接受脑膜中动脉栓塞治疗的动脉瘤或假性动脉瘤患者的原始研究和病例报告。
  • 从1690篇筛选出的文献中,600篇经过全文审阅,最终纳入28项研究/病例报告,共31例患者。

关键影像表现/征象

  • 脑膜中动脉动脉瘤或假性动脉瘤栓塞后血管造影显示所有病例均获得完全闭塞。
  • 创伤后脑膜中动脉与大脑中动脉之间可存在隐匿吻合,导致栓塞材料非目标迁移至大脑中动脉分支。

诊断标准与关键数值

  • 31例患者中,完全闭塞率为31/31。
  • 症状改善率为90.32%(28/31),残留症状为轻度偏瘫等轻微表现。
  • 并发症发生率为1/31,为非目标栓塞至大脑中动脉分支,无永久性神经功能缺损。
  • 病因分布:创伤性54.84%(17/31),肿瘤相关16.13%(5/31),医源性12.90%(4/31),其他9.68%(3/31),感染性1例。
  • 栓塞材料使用:弹簧圈38.71%(12/31),n-BCA 29.03%(9/31),EVOH(Onyx)19.35%(6/31),聚乙烯醇9.68%(3/31)。

临床应用与阅片要点

  • 阅片或介入前需评估脑膜中动脉走行区域有无创伤后形成的隐匿血管吻合,以降低非目标栓塞风险。
  • 脑膜中动脉动脉瘤或假性动脉瘤的病因以创伤为主,报告时关注外伤病史与血管损伤部位对应关系。

局限性

  • 现有数据仅来自病例报告,可推广性有限。
  • 需要更大规模的多中心队列研究来进一步确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Middle meningeal artery embolization (MMAE) is increasingly used to treat chronic subdural hematomas, arteriovenous fistulas, and meningiomas. Less commonly, MMAE is performed for pseudoaneurysms and aneurysms of the middle meningeal artery (MMA). While procedural safety and efficacy in the context of the former diseases is well know, data on MMA embolization for MMA aneurysms and pseudo-aneurysms are scarce.

PURPOSE: The purpose of this study was to systematically review the safety, efficacy, and procedural details of MMAE for pseudoaneurysms and aneurysms.

DATA SOURCE: We conducted a systematic review using PubMed/Medline and GoogleScholar, targeting studies published in English since 1994.

STUDY SELECTION: Original research studies and case reports involving adult patients (18 years of age or older) with pseudoaneurysms and aneurysms treated with MMAE were included. Data on disease etiology, complications, outcomes, procedural techniques, and embolization materials were analyzed using descriptive statistics.

DATA SYNTHESIS: Of 1690 identified studies, 600 underwent full-text review, and 28 studies/case reports focusing on MMAE for pseudoaneurysms and aneurysms were included in the final analysis. The treated cases were mainly traumatic (54.84%, 17/31), followed by tumor-related (16.13%, 5/31), iatrogenic (12.90%/4/31), miscellaneous (9.68% 3/31), and mycotic (3.2.3%, 1/31) etiologies. The most used embolization materials were coils (38.71%, 12/31), n-BCA (29.03%, 9/31), ethylene-vinyl alcohol copolymer (EVOH, Onyx) (19.35%, 6/31), and polyvinyl alcohol (9.68%, 3/31). Complete occlusion of the aneurysm or pseudoaneurysm was achieved in all cases. Symptom improvement related to MMAE occurred in 28 of 31 patients (90.32%). If symptoms remained, they were mild, such as mild hemiparesis (n = 3). Complications of MMAE occurred in 1 case, namely nontarget embolization of middle cerebral artery branches due to occult anastomoses between the MMA and middle cerebral artery related to prior trauma; however, the patient experienced no permanent deficits.

LIMITATIONS: Available data on MMAE for MMA aneurysms and pseudoaneurysms are scarce and from case reports only, limiting generalizability. Confirmation in larger, multicenter cohort studies is needed.

CONCLUSION: MMAE appears to be a safe and effective treatment for pseudoaneurysms and aneurysms, with minimal complications and high angiographic success rates.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Sharafaddin-Zadeh, Jindal, Bukhari, et al. Safety and Efficacy of Middle Meningeal Artery Aneurysm and Pseudoaneurysm Embolization: A Systematic Review. AJNR Am J Neuroradiol. 2026. PMID: 41617399. doi:10.3174/ajnr.A9132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。